Abstract
AbstractTraditional genetic testing for patients with gastrointestinal stromal tumors (GISTs) focus on those with syndromic features. To assess whether expanded genetic testing of GIST patients could identify hereditary cancer predisposition, we analyzed matched tumor-germline sequencing results from 103 patients with GISTs over a 6-year period. Germline pathogenic/likely pathogenic (P/LP) variants in GIST-associated genes (SDHA, SDHB, SDHC, NF1, KIT) were identified in 69% of patients with KIT/PDGFRA-wildtype GISTs, 63% of whom did not have any personal or family history of syndromic features. To evaluate the frequency of somatic versus germline variants identified in tumor-only sequencing of GISTs, we analyzed 499 de-identified tumor-normal pairs. P/LP variants in certain genes (e.g., BRCA1/2, SDHB) identified in tumor-only sequencing of GISTs were almost exclusively germline in origin. Our results provide guidance for genetic testing of GIST patients and indicate that germline testing should be offered to all patients with KIT/PDGFRA-wildtype GISTs regardless of their history of syndromic features.
Funder
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Marie-Josée and Henry R. Kravis Center for Molecular Oncology, the Precision, Interception and Prevention Program; the Robert and Kate Niehaus Center for Inherited Cancer Genomics
Breast Cancer Research Foundation
Susan G. Komen
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Brcic, I., Argyropoulos, A. & Liegl-Atzwanger, B. Update on molecular genetics of gastrointestinal stromal tumors. Diagnostics (Basel) https://doi.org/10.3390/diagnostics11020194 (2021).
2. Bachet, J. B. & Emile, J. F. Diagnostic criteria, specific mutations, and genetic predisposition in gastrointestinal stromal tumors. Appl. Clin. Genet. 3, 85–101 (2010).
3. Mei, L. et al. Gastrointestinal stromal tumors: The GIST of Precision Medicine. Trends Cancer 4, 74–91 (2018).
4. Gopie, P. et al. Classification of gastrointestinal stromal tumor syndromes. Endocr. Relat. Cancer 25, R49–R58 (2018).
5. Boikos, S. A. et al. Molecular subtypes of KIT/PDGFRA wild-type gastrointestinal stromal tumors: a report from the National Institutes of Health Gastrointestinal Stromal Tumor Clinic. JAMA Oncol. 2, 922–928 (2016).
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献